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ABSTRACT 
MLH1 and PMS2 proteins form the MutLα heterodimer, which plays a major role in 
DNA mismatch repair (MMR) in humans. Mutations in MMR-related proteins are 
associated with cancer, especially with colon cancer. The N-terminal region of MutLα 
comprises the N-termini of PMS2 and MLH1 and, similarly, the C-terminal region of 
MutLα is composed by the C-termini of PMS2 and MLH1, and the two are connected 
by linker region. The nuclear localization sequences (NLSs) necessary for the nuclear 
transport of the two proteins are found in this linker region. However, the exact NLS 
sequences have been controversial, with different sequences reported, particularly for 
MLH1. The individual components are not imported efficiently, presumably due to their 
C-termini masking their NLSs. In order to gain insights into the nuclear transport of 
these proteins, we solved the crystal structures of importin-α bound to peptides 
corresponding to the supposed NLSs of MLH1 and PMS2 and performed isothermal 
titration calorimetry to study their binding affinities. Both putative MLH1 and PMS2 
NLSs can bind to importin-α as monopartite NLSs, which is in agreement with some 
previous studies. However, MLH1-NLS has the highest affinity already measured by a 
natural NLS peptide, suggesting a major role of MLH1 protein in nuclear import 
compared to PMS2. Finally, the role of MLH1 and PMS2 in the nuclear transport of the 
MutLα heterodimer is discussed. 
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Abstract 
MLH1 and PMS2 proteins form the MutLα heterodimer, which plays a major role in DNA 
mismatch repair (MMR) in humans. Mutations in MMR-related proteins are associated with 
cancer, especially with colon cancer. The N-terminal region of MutLα comprises the N-
termini of PMS2 and MLH1 and, similarly, the C-terminal region of MutLα is composed by 
the C-termini of PMS2 and MLH1, and the two are connected by linker region. The nuclear 
localization sequences (NLSs) necessary for the nuclear transport of the two proteins are 
found in this linker region. However, the exact NLS sequences have been controversial, with 
different sequences reported, particularly for MLH1. The individual components are not 
imported efficiently, presumably due to their C-termini masking their NLSs. In order to gain 
insights into the nuclear transport of these proteins, we solved the crystal structures of 
importin-α bound to peptides corresponding to the supposed NLSs of MLH1 and PMS2 and 
performed isothermal titration calorimetry to study their binding affinities. Both putative 
MLH1 and PMS2 NLSs can bind to importin-α as monopartite NLSs, which is in agreement 
with some previous studies. However, MLH1-NLS has the highest affinity already measured 
by a natural NLS peptide, suggesting a major role of MLH1 protein in nuclear import 
compared to PMS2. Finally, the role of MLH1 and PMS2 in the nuclear transport of the 
MutLα heterodimer is discussed. 
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1. Introduction 
 
 The maintenance of the genome integrity and stability is important to ensure the 
organisms survival as well as the accurate transmission of the genetic code. The DNA repair 
machineries are highly conserved across species from bacteria to humans [1, 2]. The DNA 
mismatch repair (MMR) system is responsible for recognizing and repairing mismatched base 
pairs generated during DNA replication [3, 4], for removing base mismatches caused by 
spontaneous or induced base deamination, oxidation, methylation, replication errors, and also 
for activating cell death when DNA repair fails [2, 5]. The inactivation of MMR in human 
cells is associated with hereditary and sporadic human cancers [6], but particularly with 
hereditary nonpolyposis colon cancer [7, 8]. 
The MMR system is best characterized in Escherichia coli and comprises the MutS, 
MutL and MutH protein complexes [9]. The MutS homodimer identifies DNA mismatches 
and mobilizes the homodimer MutL to perform DNA repairs. This homodimer activates the 
endonuclease MutH, which recognizes the newly synthesized strand by the lack of 
methylation, promotes the strand cleavage and initiates repair by introduction of an entry-
point for the excision reaction. The activity of helicases, exonucleases, DNA polymerase III 
and ligase completes the repair [1, 10]. Other organisms have MutS and MutL homologues, 
playing the same initial steps, however the functions were split between heterodimeric 
proteins [11]. The human MutS homologue MutSα heterodimer (MSH2/MSH6 proteins) 
recognizes the new strand due the base-base mismatches, while MutSβ heterodimer (MSH2/ 
MSH3 proteins) recognizes primarily longer insertions and deletions [11]. Then, the human 
MutL homologue MutLα heterodimer (MLH1/PMS2 proteins) promotes the incision of the 
discontinuous strand, followed by exonuclease1 (EXO1) activity [1, 2]. The segment 
containing the mismatch is removed and the repair can be completed. 
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 MLH1 and PMS2 proteins form MutLα heterodimer that is essential for human MMR 
[1-3, 9, 10]. The N-terminal region of MutLα comprises the N-termini of PMS2 and MLH1 
and, similarly, the C-terminal region of MutLα is composed by the C-termini of PMS2 and 
MLH1, and the two are connected by linker region that provide flexibility to the heterodimer. 
PMS2 also displays a metal-binding motif in its C-terminal region that is essential for the 
endonuclease activity of MutLα. The putative nuclear localization sequences (NLSs) are 
found in the linker regions of both PMS2 and MLH1 [2, 3, 12]. Several DNA repair proteins 
[4] are imported into the nucleus using the classical import pathway, in which importin-α 
(Impα) recognizes a NLS present in the cargo protein [13]. The classical NLS corresponds to 
one or two clusters of basic amino acid residues, defined as monopartite and bipartite, whose 
consensus correspond to K(K/R)X(K/R) and KRX10-12K(K/R)X(K/R) (where X corresponds 
to any residue), respectively. These sequences bind to Impα through hydrophobic and polar 
contacts with two binding sites, known as major and minor binding sites. Bipartite NLSs have 
interactions with both binding sites, while monopartite NLSs bind preferentially to the major 
site [14-17]. The importin-β (Impβ) carrier binds to Impα adaptor and the heterotrimer 
(Impα/Impβ/cargo protein) is translocated to the nucleus through interactions between Impβ 
and the nucleoporins from the nuclear pore complex [18-20]. The release of cargo proteins is 
also dependent of nucleoporins (e.g., NUP50) [13, 19, 21], RanGTP and other regulatory 
proteins, and Impα and Impβ are recycled for a new import cycle [22]. 
 The nuclear import of DNA repair proteins by the classical pathway has been reported 
as an important feature that regulates the interdependence of these proteins in the DNA repair 
processes [2, 4, 23]. A previous study of Wu and colleagues [2] indicated that specific NLSs 
of MLH1 and PMS2 located in their linker regions need to be unmasked by the C-termini of 
these proteins to allow an efficient nuclear import. A second study evaluated several NLS 
mutants by immunofluorescence microscopy and confirmed the previous proposed 
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monopartite NLSs of the MutLα heterodimer [3]. More recently, a third study proposed that 
different NLSs for MLH1 (bipartite NLS) and PMS2 (monopartite NLS) are responsible for 
their translocation to the nucleus [24]. Thus, in order to provide insights about the structural 
basis of the protein import mechanism of MutLα proteins, herein we performed a 
crystallographic study with putative NLS peptides of MLH1 and PMS2 (including native and 
mutated ones) complexed to Impα and quantified the interactions of the peptides with Impα 
using isothermal titration calorimetry (ITC) assays.  
 
2. Material and Methods 
 
2.1. Synthesis of NLS peptides 
 
The peptides corresponding to human MLH1 NLS (466SSNPRKRHRED476), and their 
respective mutants MLH1-K471N (466SSNPRNRHRED476), MLH1-R472N 
(466SSNPRKNHRED476), human PMS2 NLS (571LATPNTKRFKKEE583), and mutants 
PMS2-K577N (571LATPNTNRFKKEE583), PMS2-R578N (571LATPNTKNFKKEE583) were 
synthesized by Proteimax (Brazil) with purity higher than 99%. The peptides proposed by 
Leong and co-workers [24] for MLH1 (459SEKRGPTSSNPRKRHRED476) and PMS2 
(625LAKRIKQL632) (referred herein as MLH1L and PMS2L, respectively) were also 
synthesized by the same company with purity higher than 99%. All peptides contain residues 
at their N- and C-termini additional to minimal identified NLS [4], to avoid artifactual 
binding modes at the termini [14] (Table 1). 
 
2.2. Protein expression and purification 
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Hexa-His-tagged N-terminally truncated Mus musculus importin-α2, composed of 
amino acids 70-529 (Impα), was expressed and purified by nickel affinity chromatography as 
described previously [25]. The protein was eluted using a gradient of imidazole, followed by 
dialysis. The Impα sample was stored in 20 mM Tris HCl pH 8.0, 100 mM sodium chloride, 
10 mM DTT at -20 ºC. The purity was estimated to be 98% by SDS-PAGE.  
 
2.3. Calorimetric assays 
 
 Binding affinities between the NLS peptides and Impα were determined by isothermal 
titration calorimetry (ITC). The experiments were carried out using a MicroCal iTC200 
microcalorimeter (GE Healthcare) at 20 °C. All samples were prepared in 20 mM Tris HCl, 
100 mM NaCl (pH 8.0). The sample cell was loaded with Impα (30 µM) that was individually 
titrated with each of the NLS peptides. Twenty successive injections (2 µL) of NLS peptides 
(SV40TAg (240 µM); MLH1 (450 µM), MLH1-K471N (600 µM), MLH1-R472N (600 µM); 
PMS2 (240 µM), PMS2-K577N (450, 750 and 15000 µM), PMS2-R578N (240 and 450 µM), 
MLH1L (450 µM) and PMS2L (300 µM)) were carried out into the calorimetric cell, in an 
interval of 240 s for each titration and 800-rpm homogenization speed. The thermodynamic 
parameters dissociation constant (Kd) and enthalpy change (∆H) were obtained by fitting the 
binding isotherm data as previously proposed [26]. Titrations were performed in triplicate and 
the heat dilution of each peptide was determined from control experiments and subtracted 
from their binding titrations prior to data analysis.  
 
2.4. Crystallization and crystal structure determination 
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Impα was concentrated to 18 mg/mL using a Vivaspin 20, 30 kDa (GE Healthcare) and 
stored at -20 °C. Peptides was prepared with the concentration of 16 and 19 mg/mL for 
MLH1 and PMS2 NLS, respectively. Crystallization conditions were screened using, as a 
starting point, the conditions that had been successful for other peptide complexes [14, 27]. 
The crystals were obtained using co-crystallization, by combining 1 µl of protein solution, 0.5 
µl of peptide solution (peptide/protein molar ratio of 8), and 1 µl of reservoir solution on a 
coverslip, and suspending the mixture over 0.5 ml of reservoir solution. Single crystals were 
obtained with reservoir solutions containing 0.600-0.625 M sodium citrate (pH 6) and 10 mM 
DTT after 15-20 days. The Impα complexes with mutated peptides MLH1-K471N, MLH1-
R472N, PMS2-K577N and PMS2-R578N did not result in crystals. 
X-ray diffraction data were collected from a single crystal at Laboratório Nacional de 
Luz Síncrotron (LNLS), Campinas, Brazil, with a MarMosaic 225 detector (MAR Research) 
at the beamline MX-2. The crystals were mounted in nylon loops, transiently soaked in a 
reservoir solution supplemented with 25% glycerol and flash-cooled at 100 K in a nitrogen 
stream (Oxford Nitrogen Cryojet XL- Oxford Cryosystems). Data were processed using the 
HKL2000 package [28]. The crystals had the symmetry of the space group P212121 and were 
isomorphous to other Impα-NLS peptide complexes (Table 2). The structure of the complex 
with CN-SV40TAg NLS (extended SV40TAg NLS peptide, comprising TAg amino acids 
110–132; PDB ID 1Q1S[29]), with the NLS peptides omitted, was employed as the starting 
model for crystallographic refinement. After rigid body refinement, programs Refmac5 [30] 
and Phenix [31] were used to refine the structures and the program Coot [32] was used for 
manual modeling. The final model of the Impα:MLH1 NLS complex consists of 424 residues 
of Impα (71-497), 2 peptide ligands (10 residues could be modeled in the major site and 9 
residues could be modeled in the minor site), 225 water molecules and 1 DTT molecule, 
while the final model of the Impα:PMS2 NLS complex consists of 424 residues of Impα (71-
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497), 1 peptide ligand (11 residues could be modeled in the major site), 332 water molecules 
and 1 DTT molecule (Table 2). Stereochemistry of the structure was evaluated with the 
program PROCHECK [33] and the contacts were analyzed using the program LIGPLOT [34] 
(Table 2). Coordinates and structure factors have been deposited in the PDB under accession 
code 5U5P (Impα-MLH1 NLS) and 5U5R (Impα-PMS2 NLS). 
 
3. Results 
 
3.1. Structure of Impα in complex with peptides corresponding to MLH1 and PMS2 NLSs 
 
The N-terminally truncated mouse Impα (Impα) was employed since it shares about 
94% sequence identity and the NLS-binding sites are essentially identical to the human Impα 
[17] (Suppl. Fig. 1). It was co-crystallized with peptides corresponding to MLH1 and PMS2 
NLSs as proposed previously [2,3] (Table 1). The co-crystals of wild-type NLSs were grown 
in similar conditions and were isomorphous to other mouse Impα crystals [14, 27]. The 
structures were refined at 2.17 and 2.10 Å resolution, respectively, for Impα-MLH1 NLS and 
Impα-PMS2 NLS complexes (Table 2). Electron density map of Impα-MLH1 NLS clearly 
showed electron density corresponding to the peptide in both the major and minor binding 
sites, while the Impα-PMS2 NLS complex showed electron density only in the major binding 
site (Fig. 1 and 2).  
The superposition of the Impα structure in both the MLH1 and PMS2 NLS complexes 
with full-length Impα and other monopartite NLS peptide complexes [14, 23, 35] indicates 
that Impα structures are essentially identical to the structures reported previously. The root-
mean-square deviations (RMSDs) of Cα atoms of Impα residues 72–496 are 0.35 and 0.33 Å 
between the full-length Impα (PDB ID 1IAL) and the Impα-MLH1 NLS or Impα-PMS2 NLS 
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complexes, respectively. The equivalent superposition between Impα-SV40TAg NLS (PDB 
ID 1EJL) and the Impα-MLH11 NLS or Impα-PMS2 NLS complexes yield RMSD values of 
0.34 and 0.32Å, respectively. 
 
3.2. Binding of MLH1 NLS to importin-α structure 
 
 The crystal structure of Impα-MLH1 NLS complex showed two separate volumes of 
electron density in the concave portion of Impα (Fig. 1A), corresponding to the MLH1 NLS 
peptides bound to the major and minor binding sites. The peptides could be modeled 
unambiguously in the electron density maps in antiparallel configuration when compared to 
the ARM repeats direction. The electron density found in the major NLS-binding site 
indicated the presence of 10 peptide residues (467SNPRKRHRED476, where the boldface 
residues are bound to P2-P5 positions) with an average B-factor of 44.9 Å2, which is similar to 
the average B-factor for entire Impα (45 Å2) (Fig. 1B). The residues bound to the core of the 
major NLS-binding site (residues 470–474; positions P1-P5) have lower average B-factors 
(38.5 Å2) compared to Impα. The residues R471 and K474 (positions P2 and P3 have the lowest 
B-factors (33.7 and 35.0 Å2, respectively) and the largest number of interactions between 
NLS side-chains and side-chains of conserved residues of Impα (Fig. 3). The electron density 
found at the minor binding site corresponded to 9 peptide residues (467SNPRKRHRE475, 
where the boldface residues are bound to P1' and P2' positions) with average B-factor of 53.9 
Å2
 
(Fig. 1C). The residues bound to the core of the minor NLS-binding site (residues 471–
474; positions P1'- P4') have slightly higher average B-factors (49.4 Å2) compared to the entire 
protein. The buried surface area between the protein and the peptide corresponds to 814.1 Å2 
at the major site and 645.1 Å2 at the minor site. The superposition of Cα atoms between 
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MLH1 and the simian virus 40 (SV40) large T-antigen (TAg) NLS peptides yields an RMSD 
of 0.10 Å for the major binding site and 0.35 Å for the minor binding site (Suppl. Fig. 2). 
 
3.3. Binding of PMS2 NLS to importin-α structure 
 
 The crystal structure of Impα-PMS2 NLS complex shows unambiguously a single 
volume of electron density in the concave portion of Impα (Fig. 2A), corresponding to the 
PMS2 NLS peptide bound to the major binding site. Similar to MLH1 NLS, the peptide was 
modeled unambiguously in the electron density maps in an antiparallel configuration when 
compared to the ARM repeats direction. The electron density found in the major NLS-binding 
site indicated the presence of 11 peptide residues (573TPNTKRFKKEE583, where the boldface 
residues are bound to P2-P5 positions) with an average B-factor of 42.1 Å2 (the average B-
factor for Impα is 37.4 Å2) (Fig. 2B). The residues bound to the core of the major NLS-
binding site (576–580; positions P1-P5) have lower average B-factors (31.1 Å2) compared to 
Impα. The residues K577 and K580 (positions P2 and P5) have the lowest B-factors (26.7 and 
30.0 Å2, respectively) and the largest number of interactions between NLS side-chains and 
side-chains of conserved residues of Impα (Fig. 3). The buried surface area between the 
protein and the peptide corresponds to 742.6 Å2. The superposition of Cα atoms between 
PMS2 and SV40TAg NLS peptides yields an RMSD of 0.08 Å for the major binding site 
(Suppl. Fig. 1). 
 
3.4. Calorimetric assays for the binding of NLS-peptides and Impα 
 
ITC assays were used to quantify the interactions between Impα and the wild-type 
MLH1 NLS and two of its mutants (Table 1). Analogous experiments were performed with 
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PMS2 NLSs (Table 1). These mutants were chosen based on the crystal structures of Impα-
PMS2 and MLH1 NLSs complexes and taking into account the consensus sequences for 
monopartite NLSs [15].  
The MLH1-NLS isotherm profiles could be best fitted with a model of two non-
identical and independent binding sites (Fig. 4). A dissociation constant was in the 
submicromolar range (~0.1 µM) and attributed to the major binding site, and the other 
constant corresponding to 15-fold lower affinity was attributed to the minor binding site 
(Table 3). Titrations of MLH1 NLS mutants (MLH1-K471N and MLH1-R472N) with Impα 
resulted in binding thermograms characteristic of non-interacting systems, not allowing the 
determination of thermodynamic parameters. 
PMS2-NLS titration with Impα resulted in isotherm profiles indicating that PMS2 
NLS binds only to the major binding site, consistent with crystallographic data, with moderate 
affinity (Fig. 4, Table 3). Similar to the MLH1 mutants assays, ITC experiments with PMS2-
K577N and PMS2-R578N NLS peptides resulted in binding thermograms characteristic of 
non-interacting systems, not allowing the determination of thermodynamic parameters even 
when titrated with higher molar ratios compared to the wild-type peptide. No further 
considerations related to enthalpic behavior (Fig. 4) are commented here, since the enthalpy 
values may have predominant contributions from Tris buffer used in the assays, (it displays 
high ionization enthalpy) and, also, from polar ionizable amino acids of NLS-peptides. 
A control ITC assay was performed with the peptide corresponding to SV40TAg NLS 
in order to compare its binding affinity to Impα in relation to the MLH1 and PMS2 NLSs, 
using the same experimental conditions (Fig. 4). The data was fitted with two non-identical 
and independent binding sites, based on the crystallographic data [14] and as previously 
proposed [36] (Table 3). The lower Kd value (higher affinity) was attributed to the binding of 
the SV40TAg NLS to major binding site of the Impα, which is in the same order of 
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magnitude compared to the PMS2 NLS, but one order of magnitude higher compared to the 
MLH1 NLS. The low-affinity Kd value, 10-fold higher than for the minor-site binding of the 
MLH1 NLS, was attributed to the binding of SV40TAg NLS to the minor binding site (Table 
3).  
 In addition, to test the NLS peptides proposed by Leong and co-colleagues [24], ITC 
assays with the peptides MLH1L and PMS2L using the same experimental conditions of other 
peptides (Table 3). Titrations of MLH1L peptide with Impα resulted in binding thermograms 
characteristic of non-interacting systems, not allowing the determination of thermodynamic 
parameters (Suppl. Fig. 3A). To check if the observed results were related to binding with a 
zero enthalpic change, we also performed the same experiments, but using a lower 
temperature (10 oC). Indeed, the result of this assays demonstrated a non-binding interaction 
system (Suppl. Fig. 3B). Previous ITC binding studies [37] showed that if interaction between 
ligand and protein is observed, a non-zero enthalpic change would be noticed due to the non-
zero heat capacity. In contrast, PMS2L titration with Impα resulted in isotherm profiles that 
could be best fitted with a model of two non-identical and independent binding sites (Fig. 4, 
Table 3). A dissociation constant was in the submicromolar range, being attributed to the 
major binding site, and the second constant present lower affinity (17-fold lower affinity) was 
attributed to the minor binding site (Table 3). 
 
4. DISCUSSION 
 
4.1. MLH1 and PMS2 have classical monopartite NLSs 
 
 Two amino-acid sequences of MLH1 (466SSNPRKRHRED476 where the boldface 
residues are bound to P2-P5 positions) and PMS2 (571LATPNTKRFKKEE583) proteins were 
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identified as the minimum region required for nuclear import [2, 3]. Controversially, another 
study [24] suggested a bipartite sequence for MLH1 with a linker region of only 8 residues 
(459SEKRGPTSSNPRKRHRED476, where the boldface residues are bound to P1'-P2' and P2-
P5 positions), and a different monopartite sequence for the PMS2 containing similar key 
residues (625LAKRIKQL632). The proposal of a linker region with only 8 residues for MLH1 
is inconsistent with a number of studies that have demonstrated that the linker region of 
bipartite NLSs should have a minimum length of 10 residues, otherwise it would be 
structurally impossible for the peptide to bind in both minor and major sites of the Impα 
simultaneously [17, 24, 38, 39]. In the case of the PMS2, both the proposed NLSs should be 
able to bind to Impα because they have the same key residues conserved (KRXK), which are 
able to bind at positions P2, P3, and P5, consistent with the monopartite NLS consensus 
K(K/R)X(K/R). Interesting, ITC assays (section 3.4) with the peptides  proposed by Leong 
and co-workers (MLH1L and PMS2L) [24] showed that MLH1L does not bind to Impα with 
detectable affinity and PMS2L binds to Impα with similar values compared to other 
monopartite NLS peptides (Table 3). As expected, MLH1L peptide did not bind to Impα as a 
classical bipartite NLS, but why this peptide did not bind to the major binding site is unclear 
and need further investigations. On the other hand, PMS2L binds to Impα as a classical 
monopartite NLS, thus this sequence is a possible NLS of the PMS2 protein.  
 In order to study the structural determinants of binding between the NLS peptides 
proposed for MLH1 and PMS2 and Impα [2, 3], we performed co-crystallization and solved 
the crystal structures of the Impα-MLH1 NLS and Impα-PMS2 NLS complexes. The crystal 
structure of the Impα-MLH1 NLS complex contains the MLH1 NLS peptide interacting at 
two binding sites. The residues K471, R472 and R474 bind at positions P2, P3, and P5, 
respectively, of the major binding site. These data are in agreement with the monopartite NLS 
consensus K(K/R)X(K/R) [15]. The contacts of the peptide with the minor binding site 
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include residues K471, R472, which bind at positions P1' and P2', respectively. The binding of 
monopartite NLSs at the Impα minor site is observed for several complexes [14, 35, 40, 41], 
particularly those that contain KR sequence [35, 40-42]. Structural comparisons of the MLH1 
NLS peptide, with the classical monopartite NLS peptides, such as SV40TAg NLS [14], 
Ku70, Ku80 [23], XPG1 and XPG2 NLSs [35], show that these structures are well conserved, 
as observed in Suppl. Fig. 1. In contrast to the complex with MLH1 NLS peptide, the crystal 
structure of the Impα-PMS2 NLS complex shows the peptide interacting only with the major 
binding site of the protein. This fact is probably related to the low content of K/R residues that 
would bind at the positions P0'-P4' for the PMS2 NLS, decreasing its affinity to this site (refer 
to the section 4.3). This feature is not usual for the majority for Impα-monopartite NLSs, but 
it was already observed for other NLS complexes, particularly the NLS from the DNA repair 
proteins (Ku70 and Ku80 [23]). The residues K577, K578 and K580 of the PMS2 bind at 
positions P2, P3, and P5, which is also consistent to the classical monopartite NLS consensus. 
Structural comparisons of the PMS2 peptide with classical NLS monopartite peptides shows 
that PMS2 NLS structure establishes analogous contacts observed for other NLSs (Suppl. Fig. 
1). Similar to the co-crystallization experiments with MLH1 NLS mutants, PMS2 NLS 
mutants PMS2-K577N and PMS2-R578N and Impα did not yield any crystals, which may 
also be attributed to the lack of interaction between the peptides and the protein. 
 
4.2. A comparison between binding affinities of NLSs and Impα by ITC 
 
Affinity assays are fundamental to obtain a quantitative description of structure 
recognition and to determine the potency of a protein-NLS binding. Several studies have 
measured the affinity and identify the binding behavior between NLSs and Impα, using 
different methodologies, such as solid-state binding assays, surface plasmon resonance and 
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ITC; the latter has been most widely used [23, 35, 36, 38, 39, 42-50]. However, a systematic 
affinity comparison is only possible when using the same technique, and similar conditions 
(e.g. temperature and buffer) and ideally the same equipment (e.g. ITC200, VP-ITC, Affinity 
ITC, Nano ITC). ITC assays using different NLS peptides and Impα from different families 
revealed dissociated constants varying from hundreds of nanomolar (Kd ~ 0.1 µM) to 
approximately 50 µM for the major NLS binding site. Interestingly, MLH1 NLS presents the 
highest affinity already measured using ITC assays and PMS2 is among the weakest natural 
NLSs to bind Impα at the major binding site (Table 3). PMS2 NLS displays similar affinity 
compared to the most studied monopartite NLS, SV40TAg NLS, ~2 µM (present study, [36, 
47]) using a microcalorimeter. Interestingly, XPG NLS peptides, which also have a 
combination of K/R residues at the positions P1-P5 (Table 4), have Kd values between 0.4-0.9 
µM [23]. 
On the other hand, monopartite NLS peptides usually have affinities for the minor 
binding site one order of magnitude lower compared to the major site (Kd ~ 1-10 µM). 
Interestingly, MLH1 NLS also displays a very high affinity for this site and PMS2 has no 
detectable affinity for this site. NLS peptides that bind with low affinities to this site have 
been observed using ITC assays (e.g. hPLSCR [45], Kd = 48.7 µM; XPG2 [35], Kd= 140 
µM). In contrast, for Impα from the α1 family (rice [46] and filamentous fungus [47]), the 
affinity of NLS peptides to the minor binding site is similar for the major binding site [47], or 
even stronger [46]. 
 The importance of particular interactions, such as those highlighted by MLH1-K471N, 
MLH1-R472N, PMS2-K577N and PMS2-R578N peptides, in which key residues of the 
positions P2 or P3 were mutated, can be easily characterized using the ITC technique. These 
data confirm previous results regarding to minimum consensus sequences for NLSs [15]. 
However, for both MLH1 and PMS2, Brieger and colleagues [3] observed some low-level 
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localization of the NLS mutants into the cell nuclei. This suggests that these mutants, despite 
having low affinity for Impα not detectable by ITC, may still support some low level of 
nuclear import [45]. 
 Taking into account both structural and calorimetric data of several NLS/Impα 
complexes, it is possible to get clues about the most favorable interactions between NLSs and 
the receptor. For example, in addition to P2 and P5 positions, P3 is the most important one, but 
it is not mandatory, as TXP2 NLS [51] has a Met in this position. However, from Tables 3 
and 4, it is possible to hypothesize that an Arg residue is more favorable than Lys in the 
position P3, because it is frequent in the NLSs with high affinity, e.g. MLH1 and XPG1. 
Charged residues, such as Glu and Asp at the C-termini and Ser in the N-termini, also seem to 
be favorable (Tables 3 and 4). Both observations are also seen in optimized bipartite NLS 
sequences Bimax1 and Bimax2 [14-17]. 
 
4.3. The functional role of MLH1 and PMS2 in nuclear transport  
 
 Wu and colleagues [2] demonstrated that isolated PMS2 protein is not detected in the 
nucleus for the majority of cells used in their experiments (95 %). In contrast, the same 
experiment with MLH1 resulted in 51 % of cells with the protein located only in the 
cytoplasm and the remain 49 % of cells present the protein fractioned between cytoplasm and 
nucleus. Interestingly, C-terminally truncated MLH1 and PMS2 proteins that retain their 
proposed NLSs are localized in the nucleus, but C-terminally truncated MLH1 and PMS2 
proteins that lack the putative NLSs are localized exclusively in the cytoplasm [2]. Taking 
into account these results, the authors of this study suggested that C-terminal regions of these 
proteins mask their NLSs, impairing their nuclear transport. Thus, when the MLH1/PMS2 
complex is formed, NLSs are exposed and the heterodimer can be transported to the nucleus. 
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In addition, these authors also hypothesized that the competition for dimer formation of the 
MLH1 with other proteins, such as PMS1 and MLH3, rather than PMS2, is a regulatory 
mechanism for an adaptive response during DNA repair. The results presented here are in 
agreement with the results and hypotheses of Wu and colleagues [2] and other studies [3, 52], 
where NLSs from both proteins are able to bind Impα, but the MLH1 NLS plays a major role. 
Indeed, we demonstrated that the MLH1 NLS has a very high affinity to Impα compared to 
other proteins (Table 3) and, particularly compared to the PMS2 NLS. 
 Using confocal laser microscopy, Brieger and colleagues [3] performed an extensive 
analysis of two possible NLSs for MLH1 and 11 different mutants of these sequences; 
furthermore, they also studied one NLS sequence for PMS2 and 6 different mutants. The 
results obtained here are in total agreement with this study, in which the proposed NLS for 
MLH1 was able to bind Impα with very high affinity, an order of magnitude higher compared 
to the classical SV40TAg NLS [14]. Furthermore, the NLS mutants MLH1-K471N and 
MLH1-R472N, which were found predominantly localized in the cytoplasm by Brieger and 
colleagues [3], showed no detectable affinity to Impα by ITC assays. Similarly, we also 
confirmed that the proposed sequence for PMS2 was able to bind Impα and its mutants 
K577N and R578N were unable to bind to Impα with detectable affinity. 
 Finally, one question remains to be the answered: if just one NLS is enough to 
transport the MLH1/PMS2, why both proteins contain NLSs? Considering the affinity results 
obtained here and also the more efficient transport of the full-length MLH1 compared to 
PMS2 [2], we suggest that MLH1 plays the major role in the nuclear transport of MutLα 
(MLH1/ PMS2) complex. In addition, as MLH1 dimerizes with other partners (e.g. PMS1 and 
MLH3) to form other MutL complexes, its role in the import process of other complexes [2, 
53, 54] is also probable. Possible explanations for the presence of NLS in PMS2 may include: 
(i) the observed basic sequences of residues for PMS2 is not functionally used for import 
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processes; (ii) redundancy of the NLSs to guarantee the nuclear transport of the MutLα, as 
suggested by Leong and colleagues [24]; (iii) PMS2 may be involved in other important 
processes related to other complexes, although such processes have not been observed yet; 
and (iv) different affinities may be related to regulation of the import of DNA repair proteins. 
 Although it is not possible to answer this question at this moment, similar results were 
also obtained by us for the Ku complex (Ku70/Ku80), which is involved in the non-
homologous end-joining pathway of DNA repair. Both Ku70 and Ku80 proteins have NLSs, 
but the affinity of the Ku70 protein for Impα is 4-fold stronger, compared to Ku80 [23]. 
Consequently, we hypothesized that the presence of NLSs with different affinities may be 
related to regulation of nuclear transport of DNA repair proteins, which can also use Impα 
from different families as a fine adjustment.  
 In conclusion, we showed that both MLH1 and PMS2 NLSs proposed by two 
independent studies [2, 3] can bind to Impα as classical monopartite NLSs. Furthermore, we 
demonstrated that MLH1 NLS has the highest affinity already measured by ITC of a natural 
NLS peptide and, probably, plays a major role in the nuclear import of the MutLα 
heterodimer. On basis of previous and the present studies we obtained new insights into the 
binding specificities for NLS peptides to the minor binding site. 
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TABLE LEGENDS 
TABLE 1 - NLS peptides used for crystallization and isothermal titration calorimetry assays. 
TABLE 2 - X-ray data collection and refinement statistics. 
TABLE 3 - Binding parameters of Impα and NLS peptides by isothermal titration calorimetry 
assays. 
TABLE 4 - Binding of monopartite NLSs to specific binding pockets of Impα. 
 
FIGURE LEGENDS  
Fig. 1. Crystal structure of the Impα-MLH1 NLS complex. (A) Overall structure of the Impα-MLH1 
NLS complex. Impα is shown as a ribbon diagram and MLH1 NLS peptides at the major and minor 
binding sites are shown in stick representation. Electron density omit map of the MLH1 NLS peptide 
at the (B) major and (C) minor site regions of Impα (contoured at 3.0 s.d.). The main peptide residues 
are labeled in their corresponding binding position. The main peptide residues from (D) major and (E) 
minor binding sites of Impα are identified in colored scheme (Trp - green, Asn - purple, glutamic and 
aspartic acids- red).  
Fig. 2. Crystal structure of the Impα-PMS2 NLS complex. (A) Overall structure of the Impα-PMS2 
NLS complex. Impα is shown as a ribbon diagram and the PMS2 NLS peptide at the major and minor 
binding sites are shown in stick representation. (B) Electron density omit map of the PMS2 NLS 
peptide at the major site region of Impα (contoured at 3.0 s.d.). (C) The main peptide residues from 
major binding site of Impα are identified in colored scheme (Trp - green, Asn - purple, glutamic and 
aspartic acids- red). 
Fig 3. Schematic diagram of the interactions between the MLH1 and PMS2 NLS peptides and the 
minor and major binding sites of Impα. The peptide backbone is drawn in salmon (A, MLH1 NLS) or 
cyan (B, PMS2 NLS) with the residues identified by one letter code. Impα side-chain residues 
interacting with the peptide are indicated with their names and different colors. Polar contacts are 
shown with dashed lines, and hydrophobic contacts are indicated by arcs with radiating spokes.  
Fig 4. Calorimetric titration of SV40TAg, PMS2, MLH1 and PMS2L NLS peptides with Impα. The 
upper panel shows the raw data thermogram (thermal power as a function of time) of the titration of 
Impα with (A) SV40TAg NLS, (B) PMS2 NLS, (C) MLH1 NLS and (D) PMS2L NLS. The lower 
panel shows the binding isotherm (ligand-normalized integrated heat as a function of the molar ratio). 
Titrations were performed at least in duplicate in 20 mM TrisHCl, 100 mM NaCl buffer (pH 8.0) at 20 
°C. 
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SUPPLEMENTARY FIGURE LEGENDS 
Suppl. Fig 1. Sequence alignment between Importin-α (Gene KPNA2). Importin-α protein sequences 
from Mus musculus (MmImpα) and Homo sapiens (MmImpα) (NCBI reference sequences: 
NP_034785.1and NP_002257.1, respectively) were aligned in MUSCLE software [55]. The 
highlighted residues correspond to the essential residues in NLS recognition by Impα [14], which 
indicates residues from the major binding site (orange), a residue in the linker region (grey) and the 
minor binding site (light blue).  
Suppl. Fig 2. Comparison of NLS peptides in the minor and major NLS binding  sites. NLSs from 
MLH1 (rose), PMS2 (blue), XPG1 (purple) [34], XPG2 (orange) [34], SV40TAg (green) [29], Ku70 
(orange) [23] and Ku80 (yellow) [23] are superimposed. Positions binding to the major (P1-P5) and 
minor binding sites (P1’-P4’) are identified along the chains. 
Suppl. Fig 3. Calorimetric titration of MLH1L NLS peptides with Impα. Titrations were performed at 
least in duplicate in 20 mM TrisHCl, 100 mM NaCl buffer (pH 8.0) at 20 and 10 °C, A and B 
respectively. The upper panel shows the raw data thermogram (thermal power as a function of time) of 
the titration of Impα with MLH1L NLS. The lower panel shows the binding isotherm (ligand-
normalized integrated heat as a function of the molar ratio).  
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TABLE 1. NLS peptides used for crystallization and isothermal titration calorimetry 
assays. 
Protein NLS 
MLH1* 466SSNPRKRHRED476 
MLH1 K471N** 466SSNPRNRHRED476 
MLH1 R472N** 466SSNPRKNHRED476 
PMS2* 571LATPNTKRFKKEE583 
PMS2 K577N** 571LATPNTNRFKKEE583 
PMS2 R578N** 571LATPNTKNFKKEE583 
MLH1L*** 459SEKRGPTSSNPRKRHRED476 
PMS2L*** 625LAKRIKQL632 
*[4]; **[3]; ***[24] 
 
 
TABLE 2 
X-ray data collection and refinement statistics 
Diffraction data statistics MLH1 NLS-Impα PMS2 NLS-Impα 
Unit cell dimensions (Å) a=77.21, b=89.07, c=99.14 a=77.14, b=89.54, c=97.03 
Space group P212121 
Resolution (Å) 40.0-2.17 (2.25-2.17)a 40.0-2.10 (2.18-2.10)a 
Unique reflections 36,607 39,804 
Multiplicity 6.4 (5.4)a 2.9 (2.6)a 
Completeness (%) 99.5 (97.9)a 99.7 (98.9)a 
Rmergeb (%) 7.4 (61.8)a 6.1 (46.8)a 
Average I/σ(I) 24.11 (2.4)a 18.56 (2.2)a 
Refinement statistics   
Resolution (Å) 40.0-2.17 (2.25-2.17)a 40.0-2.10 (2.18-2.10)a 
Number of reflections 36,590 39,795 
Rcryst (%)c 18.1 17.3 
Rfree (%)d 21.0 20.7 
Number of non-hydrogen atoms:  
Protein 3,247 3,217 
Peptide 164 89 
Solvent 225 332 
Mean B-factor (Å2) 45.2 47.9 
Coordinate error (Å)e 0.21 0.24 
R.m.s deviations from ideal valuese:  
Bond lengths (Å) 0.008 0.008 
Bond angles (°) 1.03 0.95 
Ramachandran plot:   
Residues in most 
favored (disallowed) 
regions (%) f 
98.0 (0.4) 99.0 (0.0) 
a
 Values in parentheses are for the highest-resolution shell.  
bRmerge=Σhkl(Σi(|Ihkl,i−〈Ihkl〉|))/Σhkl,i〈Ihkl〉, where Ihkl,i is the intensity of an individual measurement of the reflection with Miller indices 
h, k and l, and 〈Ihkl〉is the mean intensity of that reflection. Calculated for I>−3 σ(I) [28]. 
cRcryst=Σhkl(||Fobs,hkl|−|Fcalc,hkl||)/|Fobs,hkl|,where |Fobs,hkl|and |Fcalc,hkl| are the observed and calculated structure factor amplitudes, 
respectively. 
dRfree is equivalent to Rcryst but calculated with reflections (5%) omitted from the refinement process.  
e
 Calculated based on Luzzati plot with the program SFCHECK [33]. 
fCalculated with the program PROCHECK [33]. 
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Table 3. Binding parameters of Impα with NLS peptides determined by ITC 
NLS-peptides  Major binding site Minor binding site 
PMS2 Kd (µM) 1.94±0.21  
 ∆H (kcal/mol) -5.21±0.10  
PMS2-K577N Kd (µM) No binding  
 ∆H (kcal/mol)   
PMS2-R578N Kd (µM) No binding  
 ∆H (kcal/mol)   
MLH1 Kd (µM) 0.10±0.02 1.5±0.2 
 ∆H (kcal/mol) -6.5±0.7 -2.9±0.7 
MLH1-K471N Kd (µM) No binding  
 ∆H (kcal/mol)   
MLH1-R472N Kd (µM) No binding  
 ∆H (kcal/mol)   
SV40 TAg Kd (µM) 1.8±0.4 23±5 
 ∆H (kcal/mol) -9.5±0.6 4.5±0.7 
XPG1 Kd (µM) 0.45±0.05 3.4±0.5 
 ∆H (kcal/mol) -3.2±0.3 3.8±0.3 
XPG2 Kd (µM) 0.91±0.09 140±20 
 ∆H (kcal/mol) -6.9±0.8 -21±1 
PMS2L Kd (µM) 0.39±0.09 6.54±1.2 
 ∆H (kcal/mol) -2.36±0.08 -0.56±0.04 
MLH1L Kd (µM) No binding  
 ∆H (kcal/mol)   
SV40 TAg [14]; XPG1 and XPG2 [35] NLSs. No binding - No detectable binding. 
 
Table 4. Binding of monopartite NLSs to specific binding pockets of importin-α. 
Proteins     Minor site S2          Major site S1    
   P0' P1' P2' P3' P4' Linker P1 P2 P3 P4 P5    
SV40 TAg   P K K K R K V     A A P P K K K R K V E  
CN-SV40    K K R K V      ... A P P K K K R K V   
c-Myc     K R V K L       P A A K R V K L D  
mPet TM    K K R R E A         F K K K R R E A 
MLH1 S N P R K R H R E      S N P R K R H R E D  
pUL15   P P K K R A       G P P K K R A K V D  
pUL56   T R K R P R        A T R K R P R R A  
XPG1   S L K R K R         S L K R K R    
XPG2    R K R K T R        G K K R R K L R  
Ku80     
  
      ... D G P T A K K L K T E  
Ku70     
  
     ... N E G S G S K R P K    
PLSCR1     
  
           G K I S K H W  
PLSCR4   S I I R K W N                 
AR     
 
    E A G M T L G A R K L K K L G  
PMS2               T P N T K R F K K E E 
 
Consensus 
 
   K R X10-12 K 
R/
K X 
R/
K   
 
SV40 TAg [14]; CN-SV40 [29]; c-Myc [40]; mPet TM [41]; pUL15 and pUL56 [36]; XPG1 and XPG2 [35]; Ku80 and Ku70 [23]; PLSCR1 
[56]; PLSCR4 [45]; AR [44]. Consensus [15]. The positions highlighted in red correspond to the consensus NLS. The boldface positions 
correspond to exceptions to the consensus NLS. 
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Structures of Importin-α and NLS peptides of MLH1 and PMS2 proteins were solved. 
ITC assays with native and mutated MLH1 and PMS2 NLSs and Importin-α were performed. 
Both putative peptides bind to Importin-α as monopartite NLSs. 
MLH1 NLS present the highest affinity already measured for a natural NLS.   
MLH1 NLS may have a major role in the MutLα heterodimer nuclear transport. 
